L2L Microarray Analysis Tool
Results for N06AB.profile.ud50
| Results summary | View all lists in GO:BiolProc | View all genes in N06AB.profile.ud50 |
| List Name | Description | Total probes |
Expected matches |
Actual matches |
Fold Enrichment |
Binomial p-value |
|---|---|---|---|---|---|---|
| organelle organization and biogenesis | A process that is carried out at the cellular level which results in the formation, arrangement of constituent parts, or disassembly of any organelle within a cell. | 1437 | 7.10 | 16 | 2.25 | 2.70e-03 |
| RNA catabolic process | The chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage. | 64 | 0.32 | 3 | 9.48 | 4.02e-03 |
| bile acid metabolic process | The chemical reactions and pathways involving bile acids, any of a group of steroid carboxylic acids occurring in bile, where they are present as the sodium salts of their amides with glycine or taurine. | 20 | 0.10 | 2 | 20.23 | 4.38e-03 |
| negative regulation of cell growth | Any process that stops, prevents or reduces the frequency, rate or extent of cell growth. | 68 | 0.34 | 3 | 8.92 | 4.77e-03 |
| negative regulation of cell size | Any process that reduces cell size. | 68 | 0.34 | 3 | 8.92 | 4.77e-03 |
| autophagy | The process by which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of nutrient limitation and remodeling the intracellular structure for cell differentiation. | 23 | 0.11 | 2 | 17.59 | 5.77e-03 |
| negative regulation of microtubule depolymerization | Any process that stops, prevents or reduces the frequency, rate or extent of microtubule depolymerization; prevention of depolymerization of a microtubule can result from binding by 'capping' at the plus end (e.g. by interaction with another cellular protein of structure) or by exposing microtubules to a stabilizing drug such as taxol. | 25 | 0.12 | 2 | 16.18 | 6.80e-03 |
| regulation of microtubule depolymerization | Any process that modulates the frequency, rate or extent of microtubule depolymerization. | 25 | 0.12 | 2 | 16.18 | 6.80e-03 |
| microtubule depolymerization | The removal of tubulin heterodimers from one or both ends of a microtubule. | 27 | 0.13 | 2 | 14.98 | 7.90e-03 |
| regulation of microtubule polymerization or depolymerization | Any process that modulates the frequency, rate or extent of microtubule polymerization or depolymerization by the addition or removal of tubulin heterodimers from a microtubule. | 27 | 0.13 | 2 | 14.98 | 7.90e-03 |
| negative regulation of microtubule polymerization or depolymerization | Any process that stops, prevents or reduces the frequency, rate or extent of microtubule polymerization or depolymerization. | 27 | 0.13 | 2 | 14.98 | 7.90e-03 |
| negative regulation of growth | Any process that stops, prevents or reduces the rate or extent of growth, the increase in size or mass of all or part of an organism. | 83 | 0.41 | 3 | 7.31 | 8.27e-03 |
| mRNA catabolic process, nonsense-mediated decay | The nonsense-mediated mRNA decay pathway degrades mRNAs transcribed from genes in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins. | 30 | 0.15 | 2 | 13.48 | 9.70e-03 |
| microtubule polymerization or depolymerization | Assembly or disassembly of microtubules by the addition or removal of tubulin heterodimers from a microtubule. | 30 | 0.15 | 2 | 13.48 | 9.70e-03 |